Sinovac Biotech (SVA) Stock: Why It Moved
Updated Oct 23, 7:06 AM ET · latest trade in feed Oct 22, 4:00 PM ET (Finnhub)
Updated Oct 22, 2026, 4:00 PM ET · closing price
- Latest session (Thu Oct 22): $6.47, +$0.00 (+0.00%).
Sector peers moving today (Pharma & Biotech):AVTX -39.23%KRRO +29.71%BHVN +25.02%MRNA -17.57%MLTX +15.87%
- Closed at $6.47, +0.00% vs the prior close of $6.47.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Pfizer (PFE)
SVA ends flat (+0.0%) to $6.47. Closed at $6.47, +0.00% vs the prior close of $6.47. Day range $0.00–$0.00, opened at $0.00.
Why Did SVA Stock Move Today?
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Last 5 sessions at a glance, then today's full note.
| Session | Close | Change | Volume vs 50-day avg | What the data shows |
|---|---|---|---|---|
| Oct 22, 2026 | $6.47 | +0.00% | — | SVA ends flat (+0.0%) to $6.47 |
Oct 22, 2026 — SVA ends flat (+0.0%) to $6.47
- Closed at $6.47, +0.00% vs the prior close of $6.47. Day range $0.00–$0.00, opened at $0.00.
- 52-week range $6.47–$6.47; today's close sits at 50% of that range, at a new 52-week high.
Data-Driven Bull Case vs. Bear Case + Sector Peer Comparison Table
Points below restate what SEC filings and price data show. They are facts, not a recommendation.
- No clear positive signal in the price trend, filings or insider data right now.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
Sector peers · Pharmaceutical Preparations
| Ticker | Company | Last price | Day | Below 52w high | Avg $ volume (20d) |
|---|---|---|---|---|---|
| SVA | Sinovac Biotech | $6.47 | +0.00% | 0.0% | $0 |
| LLY | Eli Lilly | $1,306.69 | +2.83% | 1.1% | $2.77B |
| JNJ | Johnson & Johnson | $267.61 | +3.81% | 4.8% | $2.02B |
| ABBV | AbbVie | $285.19 | +0.14% | 2.1% | $1.43B |
| MRK | Merck | $147.24 | -1.76% | 6.2% | $1.41B |
| ABT | Abbott Laboratories | $102.51 | +1.99% | 22.4% | $1.02B |
| PFE | Pfizer | $30.42 | +1.91% | 0.1% | $851.54M |
| BMY | Bristol Myers Squibb | $63.00 | +3.08% | 8.2% | $809.92M |
| VRTX | Vertex Pharmaceuticals Inc / Ma | $535.17 | +2.03% | 4.5% | $625.84M |
SVA 52-Week High & Low
SVA's 52-week range is $6.47 to $6.47. At $6.47 it is 0.0% below the 52-week high and 0.0% above the 52-week low.
SVA 5%+ Holders: Schedule 13D / 13G Filings
Filings by investors reporting a stake of 5% or more (13D = active, 13G = passive), newest first, from SEC EDGAR:
- SCHEDULE 13D/A filed Dec 17, 2025
- SCHEDULE 13D/A filed Sep 12, 2025
- SCHEDULE 13D/A filed Jul 15, 2025
- SCHEDULE 13D/A filed Jul 14, 2025
- SCHEDULE 13D/A filed Jul 14, 2025
- SCHEDULE 13D/A filed Jul 11, 2025
Latest SVA SEC 8-K & 10-Q Filings
Every SEC filing by or about SVA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 17, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 15, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade SVA
- How much it moves: over the last 20 sessions the average daily move was 0.00% (largest 0.0%). That is a relatively calm stock.
- Liquidity: about 0 shares (≈$0) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $6.47 vs a range of $6.47–$6.47 (50% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Aug 17, 2026; 6-K Jul 15, 2026; 6-K Jun 15, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
SVA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 22, 2026 | 0.00 | 0.00 | 0.00 | 6.47 | 0 |
| Oct 14, 2026 | 0.00 | 6.47 | 6.47 | 6.47 | 0 |
About Sinovac Biotech
Sinovac Biotech (SVA) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in BEIJING. State of incorporation: Antigua and Barbuda. Fiscal year ends December 31. SEC CIK 1084201.
SVA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Simon Anderson | Director | Mar 18, 2026 |
| Shan Fu | Director | Mar 18, 2026 |
| Shuge Jiao | Director | Mar 18, 2026 |
| Yuk Lam Lo | Director | Mar 18, 2026 |
| Jiaqiang Li | Director | Apr 17, 2026 |
| Yu Min Qiu | Director | Mar 18, 2026 |
| Yu (Nmn) Wang | Director | Mar 18, 2026 |
| Yin Weidong | Chief Executive Officer | Mar 18, 2026 |
| Andrew Y Yan | Director | Mar 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Qiang (Nmn) Gao | Chief Operation Officer | Mar 18, 2026 |
| Jing (Nmn) Li | VP, Quality and Production | Mar 18, 2026 |
| Nan Wang | Chief Financial Officer | Mar 18, 2026 |
| Yin Weidong | Chief Executive Officer | Mar 18, 2026 |
| Guang (Helen) Yang | Chief Business Officer | Mar 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
SVA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
SVA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)United Therapeutics (UTHR)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Space Exploration Technologies (SPCX)Meta Platforms (META)Tesla (TSLA)Apple (AAPL)Sandisk (SNDK)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on SVA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 22, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.